Brandon M. Huffman

Also affiliated with Dana-Farber Cancer Institute

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma”.

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2005

N/A

0.503DataRank · unranked

14 citations

Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S. Kapner, Bose Kochupurakkal +23 more

Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1367

N/A

0DataRank · unranked

14 citations

Brian M. Wolpin, Stephanie K. Dougan, Srivatsan Raghavan, Harshabad Singh, Brandon M. Huffman +6 more

Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma

npj Precision Oncology(2022)10.1038/s41698-022-00304-5

N/A

0DataRank · unranked

81 citations

Betty Rouaisnel, Antoine Daina, Srivatsan Raghavan, Lauren A. Roller, Brandon M. Huffman +7 more

Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma

Cancers(2022)10.3390/cancers14246223

N/A

0DataRank · unranked

32 citations

Haley Ellis, Alexander C. Jordan, William A. Freed-Pastor, Kimberly Perez, Douglas A. Rubinson +7 more

Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors

iScience(2023)10.1016/j.isci.2023.108169

N/A

0DataRank · unranked

8 citations

Deepa T. Patil, Pratyusha Bala, Zsofia Sztupinszki, Viktória Tisza, Sándor Spisák +9 more

Circulating tumor DNA as a marker of recurrence risk in locoregional esophagogastric cancers with pathologic complete response.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4066

N/A

0DataRank · unranked

0 citations

Brandon M. Huffman, Samuel J. Klempner, Vasily N. Aushev, Jenifer Ferguson, Shruti Sharma +5 more

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1073

N/A

0DataRank · unranked

28 citations

Andressa Dias Costa, Emily Kawaler, Victoire Cardot‐Ruffino, Osama E. Rahma, Nina Beri +36 more

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008436

N/A

0DataRank · unranked

13 citations

Harshabad Singh, Lestat R. Ali, Nora Horick, S. Jennifer Wang, Megan T. Hoffman +33 more

Resident impression management within feedback conversations: A qualitative study

Medical Education(2020)10.1111/medu.14360

N/A

0DataRank · unranked

63 citations

Frederic W. Hafferty, Anjali Bhagra, Emily L. Leasure, Wil L. Santivasi, Adam P. Sawatsky +1 more

A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1027

N/A

0DataRank · unranked

6 citations

Osama E. Rahma, Kevin Tyan, Yvonne Li, Anita Giobbie‐Hurder, Benjamin L. Schlechter +18 more